These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 35777585
21. Specific binding of glucose-derivatized polymers to the asialoglycoprotein receptor of mouse primary hepatocytes. Kim SH, Goto M, Akaike T. J Biol Chem; 2001 Sep 21; 276(38):35312-9. PubMed ID: 11390372 [Abstract] [Full Text] [Related]
22. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition. Murao A, Nishikawa M, Managit C, Wong J, Kawakami S, Yamashita F, Hashida M. Pharm Res; 2002 Dec 21; 19(12):1808-14. PubMed ID: 12523658 [Abstract] [Full Text] [Related]
23. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery. Pathak PO, Nagarsenker MS, Barhate CR, Padhye SG, Dhawan VV, Bhattacharyya D, Viswanathan CL, Steiniger F, Fahr A. Carbohydr Res; 2015 May 18; 408():33-43. PubMed ID: 25841057 [Abstract] [Full Text] [Related]
24. Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells. Managit C, Kawakami S, Yamashita F, Hashida M. Int J Pharm; 2005 Sep 14; 301(1-2):255-61. PubMed ID: 16076536 [Abstract] [Full Text] [Related]
26. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M. Pharm Res; 2000 Mar 14; 17(3):306-13. PubMed ID: 10801219 [Abstract] [Full Text] [Related]
28. Lectin recognition and hepatocyte endocytosis of GalNAc-decorated nanostructured lipid carriers. Gauthier L, Chevallet M, Bulteau F, Thépaut M, Delangle P, Fieschi F, Vivès C, Texier I, Deniaud A, Gateau C. J Drug Target; 2021 Jan 14; 29(1):99-107. PubMed ID: 32936032 [Abstract] [Full Text] [Related]
29. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. Zhang XQ, Wang XL, Zhang PC, Liu ZL, Zhuo RX, Mao HQ, Leong KW. J Control Release; 2005 Feb 16; 102(3):749-63. PubMed ID: 15681095 [Abstract] [Full Text] [Related]
30. Binding of N-linked bovine fetuin glycopeptides to isolated rabbit hepatocytes: Gal/GalNAc hepatic lectin discrimination between Gal beta(1,4)GlcNAc and Gal beta(1,3)GlcNAc in a triantennary structure. Townsend RR, Hardy MR, Wong TC, Lee YC. Biochemistry; 1986 Sep 23; 25(19):5716-25. PubMed ID: 2430615 [Abstract] [Full Text] [Related]
31. Comparative affinity of synthetic multi-antennary galactosyl derivatives for the Gal/GalNAc receptor of rat hepatocytes and peritoneal macrophages. Kichler A, Schuber F. J Drug Target; 1998 Sep 23; 6(3):201-5. PubMed ID: 9888306 [Abstract] [Full Text] [Related]
32. In vivo targeting function of N-linked oligosaccharides with terminating galactose and N-acetylgalactosamine residues. Chiu MH, Tamura T, Wadhwa MS, Rice KG. J Biol Chem; 1994 Jun 10; 269(23):16195-202. PubMed ID: 8206921 [Abstract] [Full Text] [Related]
33. Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo. Rajeev KG, Nair JK, Jayaraman M, Charisse K, Taneja N, O'Shea J, Willoughby JL, Yucius K, Nguyen T, Shulga-Morskaya S, Milstein S, Liebow A, Querbes W, Borodovsky A, Fitzgerald K, Maier MA, Manoharan M. Chembiochem; 2015 Apr 13; 16(6):903-8. PubMed ID: 25786782 [Abstract] [Full Text] [Related]
34. A new N-acetylgalactosamine containing peptide as a targeting vehicle for mammalian hepatocytes via asialoglycoprotein receptor endocytosis. Wu YT, Jiaang WT, Lin KG, Huang CM, Chang CH, Sun YL, Fan KH, Hsu WC, Wang HE, Lin SB, Chen ST. Curr Drug Deliv; 2004 Apr 13; 1(2):119-27. PubMed ID: 16305377 [Abstract] [Full Text] [Related]
35. Evidence for transmembrane modulation of the ligand-binding site of the hepatocyte galactose/N-acetylgalactosamine-specific receptor. Fiete D, Brownell MD, Baenziger JU. J Biol Chem; 1983 Jan 25; 258(2):817-23. PubMed ID: 6185480 [Abstract] [Full Text] [Related]
36. Impact of Serum Proteins on the Uptake and RNAi Activity of GalNAc-Conjugated siRNAs. Agarwal S, Allard R, Darcy J, Chigas S, Gu Y, Nguyen T, Bond S, Chong S, Wu JT, Janas MM. Nucleic Acid Ther; 2021 Aug 25; 31(4):309-315. PubMed ID: 33861634 [Abstract] [Full Text] [Related]
37. Synthesis and Evaluation of New Trivalent Ligands for Hepatocyte Targeting via the Asialoglycoprotein Receptor. Reshitko GS, Yamansarov EY, Evteev SA, Lopatukhina EV, Shkil' DO, Saltykova IV, Lopukhov AV, Kovalev SV, Lobov AN, Kislyakov IV, Burenina OY, Klyachko NL, Garanina AS, Dontsova OA, Ivanenkov YA, Erofeev AS, Gorelkin PV, Beloglazkina EK, Majouga AG. Bioconjug Chem; 2020 May 20; 31(5):1313-1319. PubMed ID: 32379426 [Abstract] [Full Text] [Related]
38. Targeted delivery of atorvastatin via asialoglycoprotein receptor (ASGPR). Zhang Y, Zhang X, Zeng C, Li B, Zhang C, Li W, Hou X, Dong Y. Bioorg Med Chem; 2019 Jun 01; 27(11):2187-2191. PubMed ID: 31005367 [Abstract] [Full Text] [Related]
39. Analysis of the molecular interaction of glycosylated proteins with rabbit liver asialoglycoprotein receptors using surface plasmon resonance spectroscopy. Terada T, Nishikawa M, Yamashita F, Hashida M. J Pharm Biomed Anal; 2006 Jun 07; 41(3):966-72. PubMed ID: 16546339 [Abstract] [Full Text] [Related]
40. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs. Kawakami S, Munakata C, Fumoto S, Yamashita F, Hashida M. J Pharm Sci; 2001 Feb 07; 90(2):105-13. PubMed ID: 11169527 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]